Pharmacological Potential of Natural Products from the Red Sea II
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 1025
Special Issue Editors
Interests: bioactive microbial natural products; marine bacteria; marine endophytes; structure elucidation
Special Issues, Collections and Topics in MDPI journals
Interests: natural products; metabolomics; marine microbiology; endophytes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The marine environment has proven to be a prosperous source of diverse natural products with relevant activities, such as anticancer, anti-inflammatory, antiepileptic, immunomodulatory, antifungal, antiviral, and antiparasitic. The global marine pharmaceutical clinical pipeline comprises approximately 30 compounds originating from different marine invertebrates and marine microorganisms, which includes 8 approved drugs by the most representative approving agencies and 22 drug candidates in phase III, II, or I of drug development clinical phases. Marine invertebrates and associated microorganisms are capable of synthesizing diverse classes of secondary metabolites and, in some cases, novel chemical leads that have never been discovered by terrestrial counterparts.
The Red Sea is the world’s northernmost tropical sea which acts as an inlet of the Indian Ocean, lying between Africa and Asia. It has a surface area of roughly 450,000 km2 and is about 2250 km long, with a maximum depth of around 3000 m. Salinity-wise, the Red Sea is approximately 5% greater than the world average due to the high evaporation rate and lack of significant rivers or streams draining into it. The Red Sea is a rich and diverse ecosystem due to the 2000 km of coral reef extending along its coastline. It is inhabited by over 1000 invertebrate species and 200 soft and hard corals. Due to this high biodiversity and limited research, the Red Sea is a promising underexplored habitat for the discovery of new bioactive marine natural products.
In this new edition of our Special Issue “Pharmacological Potential of Natural Products from the Red Sea II” in Marine Drugs, we will cover the scope of isolation, structure characterization, and pharmacological potential of natural products derived from invertebrates and microorganisms collected from the Red Sea. Phylogenetic and diversity studies as well as new methodologies for isolating marine microorganisms will also be targeted in this Special Issue.
As Guest Editors, we encourage all researchers interested in Red Sea marine research to contribute their latest research findings. We hope this issue will help us to gain more knowledge about marine organisms and microbes as leading sources for drug discovery in such an underexplored habitat.
Dr. Mostafa Rateb
Prof. Dr. Usama Ramadan Abdelmohsen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- red sea
- marine invertebrates
- marine microbes
- drug discovery
- bioactive natural products
- structure elucidation
- omics
- genome mining
- in silico analysis
Related Special Issue
- Bioactive Natural Products from the Red Sea in Marine Drugs (10 articles)
